Post-IPO Equity Companies in San Diego

Forza Innovations is a health-tech wearable performance business.

Ventyx is a biopharmaceutical company focused on advancing oral therapies for patients living with autoimmune and inflammatory disorders.

Synapse Energy Economics is a consulting firm providing economic and policy analysis for the electric power sector.

Poseida Therapeutics is a biopharmaceutical company utilizing gene engineering capabilities to develop targeted therapeutics.

Helport is an artificial intelligence platform offering generative AI, CRM integration, and BPO solutions to improve customer communication.

Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.

RYVYL is a fully-integrated, secure, Blockchain-based POS system.

Erasca is a developer of oncology drugs intended to provide precision oncology options.

Artiva Biotherapeutics is a biotech company focused on developing and commercializing allogeneic natural killer (NK) cell therapies.

Reneo Pharmaceuticals is an operator of a pharmaceutical company used to develop therapies for patients with orphan metabolic diseases.

Telesis Bio is a biotech company that empowers researchers with the tools to secure design, code, and create synthetic DNA and mRNA.

ImageneBio is dedicated to developing therapeutics for patients with immunological, autoimmune and inflammatory diseases

Calidi Biotherapeutics is a clinical-stage biotechnology company developing immunotherapies for cancer.

Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders.

Conduit Pharmaceuticals is a clinical-stage biopharmaceutical company providing solutions for the unmet medical needs of patients.

Hempacco is a manufacturing company producing innovative, filtered hemp smokable products.

Skye Bioscience is a pharmaceutical company developing new therapeutic outcomes for diseases.

Effector Therapeutics is an early-stage company focused on the discovery and development of small molecule cancer therapeutics.

Nuvve is accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) technology.

Longboard Pharmaceuticals delivers medicines with optimized pharmacology and pharmacokinetics to patients with rare neurological diseases.

Belite Bio is a clinical stage biopharmaceutical drug development company.

Contineum Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.